7th Annual Peptides Congress: Virtual | 27 – 28 August 2020 | Alex Batchelor to present

The Peptides Congress includes over 150 attendees working in peptides and oligonucleotides, representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions.

Over 40 case studies, presentations and panel discussions focused on the key issues in peptide technologies, therapeutics case studies, discovery & development of oligonucleotide therapeutics, manufacturing and process development.

Alex Batchelor, our CEO will be presenting at this congress on August 28th.

Juan Bolivar Gonzalez and Marta Ponce will be attending the congress and presenting a poster.


Immuno Series UK: Virtual | 24 – 25 August 2020

Join over 500 leaders at the forefront of research into the immune system, connecting experts from pharma, biotech and academia working on the delivery of innovative immunotherapies.

Niloofar Karaji and Marta Ponce will be
digitally present at this conference.


BIO Digital | 8 – 12 June 2020

For 2020, the BIO International Convention will transition to a new, virtual event format, BIO Digital. This virtual gathering of the global biotech industry provides access to key partners via BIO One-on-One Partnering, educational resources to help drive your business, and the insights you need to continue critical research and development.

We may not be able to gather in person, but nothing stops innovation.

Cora Griffin, Orbit’s BD Manager will be available digitally for partnering meetings.


BIO-EUROPE Spring, DELIVERED DIGITALLY | 23 – 27 March 2020

A situation out of our control is preventing us from doing business in a face-to-face environment, so we’ve come together to offer an alternative solution. We will now be delivering BIO-Europe Spring as a fully digital event, offering virtual partnering, online company presentations, pre-recorded panels and a virtual exhibit. The digital event will take place March 23–27, 2020.

Alex Batchelor, Orbit’s CEO will be available digitally for partnering meetings.


LSX World Congress, London | 4 – 5 February 2020

LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly listed life science giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.

The industry’s c-suite will be joined by the sector’s most active investors, pharma and health-tech BD&L teams, key stakeholders and top tier service companies who are moving the sector forward..

Cora Griffin, Orbit’s BD Manager will be available in London for partnering meetings.


Biotech Showcase, San Francisco | 13 – 15 January 2020

The investor conference that drives the future of drug development.

With more than $400 billion in capital represented, Biotech Showcase, January 13–15, 2020, is one of the industry’s leading investor conferences expecting more than 3,700 attendees, 2,200 companies, and over 1,000 investors.

Alex Batchelor, CEO of Orbit Discovery will be available in San Francisco for partnering meetings.


Synthetic Biology UK, Warwick | 9 – 10 December 2019

Synthetic biology is a convergence of multiple fields that can generate both improved understanding of biological systems as well as cutting-edge biotechnology.

Synthetic Biology UK 2019 will explore the unique opportunities of research in a number of areas of synthetic biology, establishing likely future directions and facilitating discussion about appropriate strategies. It will provide an excellent framework for younger scientists and engineers to learn about burgeoning new areas of activity, including the engineering of microbial communities and of microbial-plant interactions.

For Orbit Discovery Christel Compper will attend.


OBN BioLearn, Oxford | 19 November 2019

This course represents an excellent opportunity for staff who are new to the drug discovery industry, those in non-scientific roles or beginning careers as a scientist to gain or develop an in-depth knowledge of the sector.

During this half-day course the structure and commercial environment of the biopharmaceutical industry including key technical aspects of the drug development process will be covered.

For Orbit Discovery we will have Simon Bushell, Maryana Baran, Giulia Poloni, Juan Bolivar Gonzalez and Giovanna Cacciola attend.


PEGS Europe, Lisbon | 18 – 22 November 2019

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2018, more than 1,100 delegates from 36 countries, including 70% from pharma and biotech organizations, convened in beautiful Lisbon, Portugal to discuss the latest advances in protein and antibody engineering.

For Orbit Discovery, Li Phing Liew will attend this conference.


BIO-Europe, Hamburg | 11 – 13 November 2019

As Europe’s largest life science partnering conference, BIO-Europe offers countless opportunities to engage with global life science partners. Empower yourself with knowledge from key biotech and pharma leaders who will discuss the latest industry trends in workshops and panels.

For Orbit Discovery, Cora Griffin and Alex Batchelor will be available for partnering meetings.

Close Menu